NEW YORK, March 28 (GenomeWeb News) - PerkinElmer said today it will provide reagents, instrumentation, and scientific support for the National Institute of Health's Chemical Genomics Center.
Under the terms of the deal, NCGC gets access to PerkinElmers AlphaScreen, Lance, and Delfia technologies as well as the company's assay and protocol researchers.
PerkinElmer's remuneration was not released.